Therapeutic equivalence? [Design Issues]

posted by bjkim97  – Korea / Seoul, 2011-02-23 12:06 (5103 d 12:38 ago) – Posting: # 6663
Views: 5,752

Dear Dan

I understand your opinion. Anti-Cancer is not all cytotoxic. I agree with your opinion

You say about the imatinib that "No problem"
Then if so, did you think the tests are performed.

Please tell me studying about the imatinib of healthy volunteer.
Safety, AE (adverse event), specific issue eg.

Your advice is very helpful to me!

Kind regard
BJ

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
36 visitors (0 registered, 36 guests [including 3 identified bots]).
Forum time: 00:45 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5